Hadasit Bio (HDST) - Cash Flow Conversion Efficiency

Latest as of June 2022: -0.009x

Based on the latest financial reports, Hadasit Bio (HDST) has a cash flow conversion efficiency ratio of -0.009x as of June 2022. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (ILA-360.50K ≈ $-966.49 USD) by net assets (ILA39.81 Million ≈ $106.73K USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. See how leveraged is Hadasit Bio's balance sheet to measure how much of total assets are equity-financed.

Hadasit Bio - Cash Flow Conversion Efficiency Trend (2013–2022)

This chart illustrates how Hadasit Bio's cash flow conversion efficiency has evolved over time, based on yearly financial data. Check HDST operating cash flow to net income to evaluate the quality of earnings relative to operating cash generation.

Hadasit Bio Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Hadasit Bio ranked by their cash flow conversion efficiency.

Company	Cash Flow Conversion Efficiency
Oldfields Holdings Ltd AU:OLH	-0.443x
Canada One Mining Corp V:CONE	0.009x
DevvStream Corp. Common Stock NASDAQ:DEVS	0.150x
PREMIA FINANCE O.N. F:81U	N/A
TELES Informationstechnologien AG XETRA:TLIK	N/A
Capella Minerals Ltd V:CMIL	0.133x
Frontier Developments Plc LSE:FDEV	0.241x
CPT GLOBAL LTD F:714	N/A

Annual Cash Flow Conversion Efficiency for Hadasit Bio (2013–2022)

The table below shows the annual cash flow conversion efficiency of Hadasit Bio from 2013 to 2022. For the full company profile with market capitalisation and key ratios, see HDST company net worth.

Year	Net Assets	Operating Cash Flow	Cash Flow Conversion Efficiency	Change
2022-12-31	ILA35.08 Million ≈ $94.04K	ILA-2.12 Million ≈ $-5.67K	-0.060x	-88.52%
2021-12-31	ILA65.69 Million ≈ $176.12K	ILA-2.10 Million ≈ $-5.63K	-0.032x	+70.05%
2020-12-31	ILA37.11 Million ≈ $99.49K	ILA-3.96 Million ≈ $-10.62K	-0.107x	+81.53%
2019-12-31	ILA5.50 Million ≈ $14.75K	ILA-3.18 Million ≈ $-8.53K	-0.578x	-20.50%
2018-12-31	ILA34.30 Million ≈ $91.96K	ILA-16.46 Million ≈ $-44.12K	-0.480x	-65.93%
2017-12-31	ILA60.79 Million ≈ $162.97K	ILA-17.57 Million ≈ $-47.12K	-0.289x	-21.36%
2016-12-31	ILA61.62 Million ≈ $165.20K	ILA-14.68 Million ≈ $-39.36K	-0.238x	-8.35%
2015-12-31	ILA60.30 Million ≈ $161.66K	ILA-13.26 Million ≈ $-35.55K	-0.220x	+60.29%
2014-12-31	ILA22.11 Million ≈ $59.28K	ILA-12.24 Million ≈ $-32.82K	-0.554x	-18.68%
2013-12-31	ILA24.89 Million ≈ $66.72K	ILA-11.61 Million ≈ $-31.13K	-0.467x	--

About Hadasit Bio

TA:HDST Israel Biotechnology & Medical Research

Market Cap

$1.81 Million

ILA674.18 Million ILA

Market Cap Rank

#30086 Global

#443 in Israel

Share Price

ILA60.80

Change (1 day)

-1.78%

52-Week Range

ILA30.00 - ILA83.00

All Time High

ILA2847.77